- Research works
- 65 ▲ 27% vs 2013–17
- Citations
- 3.9k 59.7 per fractional work
- Top-10% rate
- 27.0% record average 16.5%
- Open access
- 55% world 28%
Not ranked overall: Sigmovir Biosystems (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 12.0×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 12.0×
- Immunology and Microbiology 3.6×
- Neuroscience 2.8×
- Mathematics 2.5×
- Medicine 2.3×
- Biochemistry, Genetics and Molecular Biology 1.7×
- Veterinary 1.6×
- Nursing 1.2×
- Computer Science 0.9×
- Chemistry 0.9×
- Business, Management and Accounting 0.9×
- Energy 0.8×
- Engineering 0.6×
- Social Sciences 0.5×
- Health Professions 0.4×
- Agricultural and Biological Sciences 0.3×
- Environmental Science 0.1×
Which keywords describe research at Sigmovir Biosystems (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Pathogenesis, Vaccine, Vaccine Development, Disease Burden, Human Metapneumovirus, Respiratory Syncytial Virus and Immune Response.
- Surface Roughness
- Bronchopulmonary Dysplasia
- Diagnostics
- Protein Identification
- Solar Dynamics Observatory
- Genetic Variation
- Viral Pathogenesis
- Glycosylation
- SARS-CoV-2
- H1N1
- Virus
- Toll-like Receptors
- Proteomics
- Norovirus
- Mass Spectrometry
- Infection
- Inflammation
- Human Metapneumovirus
- Vaccine Development
- Pathogenesis
- Epidemiology
- Vaccine
- Disease Burden
- Respiratory Syncytial Virus
- Immune Response
- Genomics
- Pandemic
- Rotavirus
- Solar Wind
- Pattern Recognition Receptors
- Antibodies
- Influenza
- Cytokine-Mediated Link
- Innate Antiviral Responses
- Coronal Mass Ejections
- Immunity
- Innate Immunity
- Quantitative Analysis
- Antimicrobial Resistance
- Preterm Infants
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology17▲ 6.6×24 topics
- Pathogenesis7▲ 18×6 topics
- Vaccine6▲ 25×8 topics
- Vaccine Development6▲ 33×5 topics
- Disease Burden5▲ 104×2 topics
- Human Metapneumovirus5▲ 179×1 topic
- Respiratory Syncytial Virus5▲ 179×1 topic
- Inflammation4▲ 2.4×12 topics
- Immune Response3▲ 8.4×7 topics
- Infection3▲ 18×3 topics
- Genomics3▲ 14×5 topics
- Mass Spectrometry3▲ 22×5 topics
- Pandemic3▲ 9.8×3 topics
- Norovirus3▲ 72×1 topic
- Rotavirus3▲ 72×1 topic
- Proteomics2▲ 32×2 topics
- Solar Wind2▲ 27×2 topics
- Toll-like Receptors2▲ 22×3 topics
- Pattern Recognition Receptors2▲ 25×3 topics
- Virus2▲ 28×2 topics
- Antibodies2▲ 37×2 topics
- H1N12▲ 84×1 topic
- Influenza2▲ 64×1 topic
- SARS-CoV-22▲ 20×3 topics
- Cytokine-Mediated Link2▲ 39×1 topic
- Glycosylation2▲ 12×2 topics
- Innate Antiviral Responses2▲ 39×1 topic
- Viral Pathogenesis2▲ 34×2 topics
- Coronal Mass Ejections2▲ 33×1 topic
- Genetic Variation2▲ 7.2×3 topics
- Immunity2▲ 6.8×5 topics
- Solar Dynamics Observatory2▲ 33×1 topic
- Innate Immunity1▲ 6.2×5 topics
- Protein Identification1▲ 92×1 topic
- Quantitative Analysis1▲ 13×1 topic
- Diagnostics1▲ 24×2 topics
- Antimicrobial Resistance1▲ 7.6×2 topics
- Bronchopulmonary Dysplasia1▲ 22×1 topic
- Preterm Infants1▲ 12×1 topic
- Surface Roughness1▲ 14×2 topics
Which research topics does Sigmovir Biosystems (United States) publish most on?
By volume in 2022–2025: Digital Transformation in Industry, Respiratory viral infections research, Viral gastroenteritis research and epidemiology and Statistical Methods in Clinical Trials.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Digital Transformation in Industry Industrial and Manufacturing Engineering 1 works
- 2 Respiratory viral infections research Epidemiology 1 works
- 3 Viral gastroenteritis research and epidemiology Infectious Diseases 0 works
- 4 Statistical Methods in Clinical Trials Statistics and Probability 0 works
- 5 Education and Character Development Education 0 works
- 6 Educational Methods and Media Use Information Systems 0 works
- 7 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
- 8 COVID-19 Clinical Research Studies Infectious Diseases 0 works
- 9 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 10 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Sigmovir Biosystems (United States)'s research output changed?
Output in 2018–2022 was 27% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Rockville
- United States Nuclear Regulatory Commission
- Signal Processing (United States)
- Center for Devices and Radiological Health
- Agency for Healthcare Research and Quality
- Orthopaedic Center
- Biomedical Research Institute
- Westat (United States)
- Research Applications (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.